PharmacyCodes



Tridezibarbitur en es it fr

Tridezibarbitur Brand names, Tridezibarbitur Analogs

Tridezibarbitur Brand Names Mixture

  • No information avaliable

Tridezibarbitur Chemical_Formula

C12H12N2O3

Tridezibarbitur RX_link

No information avaliable

Tridezibarbitur fda sheet

Tridezibarbitur msds (material safety sheet)

Tridezibarbitur MSDS

Tridezibarbitur Synthesis Reference

Hoerlein, U.S. Pat. 1,025,872 (1912)

Tridezibarbitur Molecular Weight

232.235 g/mol

Tridezibarbitur Melting Point

174 oC

Tridezibarbitur H2O Solubility

<0.01 g/100 mL

Tridezibarbitur State

Solid

Tridezibarbitur LogP

1.777

Tridezibarbitur Dosage Forms

Tablet; Elixir

Tridezibarbitur Indication

For the treatment of Epilepsy

Tridezibarbitur Pharmacology

Phenobarbital, the longest-acting barbiturate, is used for its anticonvulsant and sedative-hypnotic properties in the management of all seizure disorders except absence (petit mal).

Tridezibarbitur Absorption

Absorbed in varying degrees following oral, rectal or parenteral administration. The salts are more rapidly absorbed than are the acids. The rate of absorption is increased if the sodium salt is ingested as a dilute solution or taken on an empty stomach

Tridezibarbitur side effects and Toxicity

CNS and respiratory depression which may progress to Cheyne-Stokes respiration, areflexia, constriction of the pupils to a slight degree (though in severe poisoning they may wshow paralytic dilation), oliguria, tachycardia, hypotension, lowered body temperature, and coma. Typical shock syndrome (apnea, circulatory collapse, respiratory arrest, and death) may occur.

Tridezibarbitur Patient Information

PATIENT INFORMATION

Practitioners should give the following information and instructions to patients receiving barbiturates:

1. The use of phenobarbital carries with it an associated risk of psychological and/or physical dependence.
The patient should be warned against increasing the dose of the drug without consulting a physician.

2. Phenobarbital may impair mental and/or physical abilities required for the performance of potentially
hazardous tasks (e.g., driving, operating machinery, etc.).

3. Alcohol should not be consumed while taking phenobarbital. Concurrent use of phenobarbital with other
CNS depressants (e.g., alcohol, narcotics, tranquilizers, and antihistamines) may result in additional CNS
depressant

Tridezibarbitur Organisms Affected

Humans and other mammals